SYRS | Syros Pharmaceuticals
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 57.17M Prev closed: Open: 2.1 High: 2.1 Low: 1.86 52 week low: 1.76 52 week high: 13.46 Dividends: No Dividends Next ER: August 9, 2022 Before Market Opens
Company Profile Syros is redefining the power of small molecules to control the expression of genes with the aim of providing a profound benefit for patients. We are advancing a pipeline of gene control medicines for cancer and monogenic diseases.
Earnings History Date EPS / Forecast Revenue / Forecast November 10, 2022 August 9, 2022 -0.54 / -0.4086.28M / 4.74MBeat! May 16, 2022 -0.4 / -0.475.47M / 4.92MBeat! March 15, 2022 -0.38 / -0.46297.8M / 4.81MBeat! November 5, 2021 -0.41 / -0.43755.7M / 4.49MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 9, 2022 0.928 0.860 1.050
0.851
1.04M -4.83% Aug 8, 2022 0.975 0.890 0.980
0.890
619.25K 8.34% Aug 5, 2022 0.900 0.852 0.900
0.800
1.09M -0.95% Aug 4, 2022 0.909 1.020 1.100
0.900
3.77M 3.34% Aug 3, 2022 0.879 0.835 0.910
0.820
6.28M 7.63% Aug 2, 2022 0.817 0.800 0.843
0.791
226.86K 3.22% Aug 1, 2022 0.791 0.820 0.820
0.781
321.26K 0.82% Jul 29, 2022 0.785 0.850 0.850
0.785
338.92K -4.74% Jul 28, 2022 0.824 0.881 0.890
0.784
615.33K -5.67% Jul 27, 2022 0.874 0.880 0.890
0.850
347.73K 0.41% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Are Options Traders Betting on a Big Move in Syros (SYRS) Stock? finance.yahoo.com Feb 3, 2022 8:38 am
Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones finance.yahoo.com Feb 3, 2022 7:30 am
Syros Receives FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS finance.yahoo.com Feb 2, 2022 4:01 pm
Here's Why Syros Pharmaceuticals (NASDAQ:SYRS) Can Manage Its Debt Despite Losing Money finance.yahoo.com Dec 28, 2021 8:53 am
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com Nov 5, 2021 8:55 am
Syros Pharmaceuticals (NASDAQ:SYRS) investors are sitting on a loss of 63% if they invested five years ago finance.yahoo.com Oct 29, 2021 11:37 am
Syros Pharmaceuticals, Inc. (SYRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release finance.yahoo.com Oct 28, 2021 3:05 pm
Syros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer finance.yahoo.com Oct 12, 2021 8:00 am
Cathie Wood is Dumping These 15 Stocks finance.yahoo.com Sep 30, 2021 2:07 pm
Syros Reports Inducement Grant to Chief Commercial Officer under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Sep 28, 2021 4:01 pm
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings finance.yahoo.com Sep 20, 2021 3:56 pm
Syros Announces Appointment of Deborah Dunsire, M.D., to Its Board of Directors finance.yahoo.com Sep 10, 2021 7:30 am
Were Hedge Funds Right About Syros Pharmaceuticals, Inc. (SYRS)? finance.yahoo.com Jul 26, 2021 11:18 am
Syros Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Jun 22, 2021 2:30 pm
Syros Acquires Clinical-Stage Drug Candidate for Acute Promyelocytic Leukemia, Expanding Its Pipeline of Targeted Therapies for Hematologic Malignancies finance.yahoo.com Jun 22, 2021 12:31 pm
Syros to Present New Data from Phase 2 Clinical Trial of SY-1425 in Oral Presentations at 62nd ASH Annual Meeting finance.yahoo.com Jun 22, 2021 10:12 am SAFM, WISH, MVIS and MNOV among after-hours movers seekingalpha.com Jun 22, 2021 5:40 am Syros Pharmaceuticals Inc (SYRS) Up 4.43% in Premarket Trading investorsobserver.com Jun 1, 2021 1:19 pm Cathie Wood’s ARK Invest Sells 3.6 Million Shares of Syros Pharma 247wallst.com Jun 1, 2021 1:19 pm Syros Pharmaceuticals Inc (SYRS) Up 6.98% in Premarket Trading investorsobserver.com Jun 1, 2021 1:19 pm This company doesn't provide a dividend.
Key Persons CEO : Nancy A Simonian CFO : Joseph J. Ferra Chief Medical Officer : David A. Roth Talk about Syros Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?
